BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 25149378)

  • 1. Expression level of pluripotent genes in incomplete reprogramming.
    Zhao X; Li Q; Jiang WM; Liu HY; Ma N; Zhou Z; Li LJ; Huang YH; Ma YL
    Asian Pac J Trop Med; 2014 Aug; 7(8):639-644. PubMed ID: 25149378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear reprogramming with a non-integrating human RNA virus.
    Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
    Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducing goat pluripotent stem cells with four transcription factor mRNAs that activate endogenous promoters.
    Chen H; Zuo Q; Wang Y; Song J; Yang H; Zhang Y; Li B
    BMC Biotechnol; 2017 Feb; 17(1):11. PubMed ID: 28193206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
    Okada M; Yoneda Y
    Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cells from goat fibroblasts.
    Song H; Li H; Huang M; Xu D; Gu C; Wang Z; Dong F; Wang F
    Mol Reprod Dev; 2013 Dec; 80(12):1009-17. PubMed ID: 24123501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular signature and colony morphology affect in vitro pluripotency of porcine induced pluripotent stem cells.
    Setthawong P; Phakdeedindan P; Techakumphu M; Tharasanit T
    Reprod Domest Anim; 2021 Aug; 56(8):1104-1116. PubMed ID: 34013645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief report: combined chemical treatment enables Oct4-induced reprogramming from mouse embryonic fibroblasts.
    Yuan X; Wan H; Zhao X; Zhu S; Zhou Q; Ding S
    Stem Cells; 2011 Mar; 29(3):549-53. PubMed ID: 21425417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermediate Standstill Clones Trapped in the Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells.
    Zhang L; Wang Y; Zhang Y; Wang L; Huang H
    Cell Reprogram; 2020 Apr; 22(2):99-105. PubMed ID: 32182120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.
    Kunisato A; Wakatsuki M; Kodama Y; Shinba H; Ishida I; Nagao K
    Stem Cells Dev; 2010 Feb; 19(2):229-38. PubMed ID: 19558219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
    Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
    Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog.
    Moon JH; Yun W; Kim J; Hyeon S; Kang PJ; Park G; Kim A; Oh S; Whang KY; Kim DW; Yoon BS; You S
    Biochem Biophys Res Commun; 2013 Feb; 431(3):444-9. PubMed ID: 23333380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig.
    Choi KH; Park JK; Son D; Hwang JY; Lee DK; Ka H; Park J; Lee CK
    PLoS One; 2016; 11(6):e0158046. PubMed ID: 27336671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sox2 expression effects on direct reprogramming efficiency as determined by alternative somatic cell fate.
    Yamaguchi S; Hirano K; Nagata S; Tada T
    Stem Cell Res; 2011 Mar; 6(2):177-86. PubMed ID: 21130722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
    Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K
    Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming human endometrial fibroblast into induced pluripotent stem cells.
    Chen YJ; Liou YJ; Chang CM; Li HY; Chen CY; Twu NF; Yen MS; Chang YL; Peng CH; Chiou SH; Chen CP; Chao KC
    Taiwan J Obstet Gynecol; 2012 Mar; 51(1):35-42. PubMed ID: 22482966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc.
    Tavernier G; Wolfrum K; Demeester J; De Smedt SC; Adjaye J; Rejman J
    Biomaterials; 2012 Jan; 33(2):412-7. PubMed ID: 21993235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MyoD gene suppression by Oct4 is required for reprogramming in myoblasts to produce induced pluripotent stem cells.
    Watanabe S; Hirai H; Asakura Y; Tastad C; Verma M; Keller C; Dutton JR; Asakura A
    Stem Cells; 2011 Mar; 29(3):505-16. PubMed ID: 21425413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced OCT4 transcriptional activity substitutes for exogenous SOX2 in cellular reprogramming.
    Marthaler AG; Adachi K; Tiemann U; Wu G; Sabour D; Velychko S; Kleiter I; Schöler HR; Tapia N
    Sci Rep; 2016 Jan; 6():19415. PubMed ID: 26762895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.